Classification of Reactions to Nonsteroidal Antiinflammatory Drugs

Immunology and Allergy Clinics of North America

Volumn 33, Issue 2, 2013, Pages 135-145

  Kowalski, Marek L ^a   Stevenson, Donald D ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Adverse effects; Aspirin; Aspirin exacerbated respiratory disease (AERD); Hypersensitivity; Nonsteroidal antiinflammatory drugs

Indexed keywords

ACETYLSALICYLIC ACID; CARPROFEN; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; FENOPROFEN; FLURBIPROFEN; IBUPROFEN; IMMUNOGLOBULIN E; INDOMETACIN; KETOPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OXYPHENBUTAZONE; PHENAZONE; PHENYLBUTAZONE; SALICYLIC ACID;

ABDOMINAL PAIN; AGRANULOCYTOSIS; ANAPHYLAXIS; ANEMIA; ANGIONEUROTIC EDEMA; ANTIINFLAMMATORY ACTIVITY; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; AUTOINFLAMMATORY DISEASE; BLEEDING; CROSS REACTION; DRESS SYNDROME; DRUG HYPERSENSITIVITY; DRUG STRUCTURE; DYSPNEA; ERYTHEMA MULTIFORME; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL TOXICITY; HEMARTHROSIS; HUMAN; IMMUNOGENICITY; LARYNX SPASM; NEPHRITIS; NEPHROTOXICITY; NOSE POLYP; PAIN; PNEUMONIA; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; REVIEW; RHEUMATIC DISEASE; RHINITIS; RHINORRHEA; SKIN BLEEDING; STEVENS JOHNSON SYNDROME; T LYMPHOCYTE; TOXIC EPIDERMAL NECROLYSIS; TOXIC HEPATITIS; URINARY TRACT HEMORRHAGE; URTICARIA;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; DRUG HYPERSENSITIVITY; HISTORY, 20TH CENTURY; HUMANS;

EID: 84877024597     PISSN: 08898561     EISSN: 15578607     Source Type: Journal    
DOI: 10.1016/j.iac.2012.10.008     Document Type: Review

References (34)

1. Conaghan P.G. A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy and toxicity. Rheumatol Int 2012, 32:1491-1502.
2. Widal M.F., Abrami P., Lenmoyes J. Anaphylaxie et idiosyncrasie. Presse Med 1922, 30:189-193. [in French].
3. Brune K., Hinz B. The discovery and development of antiinflammatory drugs. Arthritis Rheum 2004, 50:2391-2399.
4. Vane J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971, 43:232-235.
5. Vane J.R. The mode of action of aspirin and similar compounds. J Allergy Clin Immunol 1976, 58:691-712.
6. Meade E.A., Smith W.L., DeWitt D.L. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1993, 268:6610-6614.
7. Smith W.L., DeWitt D.L. Prostaglandin endoperoxide H synthases-1 and -2. Adv Immunol 1996, 62:167-215.
8. Fitzgerald G.A., Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 2001, 345:433-442.
9. Rao P., Knaus E.E. Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. J Pharm Pharm Sci 2008, 11(2):81s-110s.
10. Chiang N., Serhan C.N. New mechanism for an old drug: aspirin triggers anti-inflammatory lipid mediators with gender implications. Compr Ther 2006, 32:150-157.
11. Schrör K. Pharmacology and cellular/molecular mechanisms of action of aspirin and non-aspirin NSAIDs in colorectal cancer. Best Pract Res Clin Gastroenterol 2011, 25(4-5):473-484.
12. Kowalski M.L., Bienkiewicz B., Woszczek G., et al. Diagnosis of pyrazolone drug sensitivity: clinical history versus skin testing and in vitro testing. Allergy Asthma Proc 1999, 20:347-352.
13. Himly M., Jahn-Schmid B., Pittertschatscher K., et al. IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone. J Allergy Clin Immunol 2003, 111:882-888.
14. WHO. International drug monitoring: the role of national centres. World Health Organ Tech Rep Ser 1972, 498:1-25.
15. Ralph Edwards I.R., Aronson J.K. Adverse drug reactions: definitions, diagnosis and management. Lancet 2000, 356:1255-1259.
16. Rawlins M.D., Thompson J.W. Pathogenesis of adverse drug reactions. Textbook of adverse drug reactions 1977, 10. Oxford University Press, Oxford (United Kingdom). D.M. Davies (Ed.).
17. Johansson S.G., Hourihane J.O., Bousquet J., et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature Task Force. Allergy 2001, 56:813-824.
18. Johansson S.G., Bieber T., Dahl R., et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004, 113:832-836.
19. Kowalski M.L., Makowska J.S., Blanca M., et al. Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA and GA2LEN/HANNA. Allergy 2011, 66:818-829.
20. Hirschberg Mitheilung uber einen fall von Nebenwirkung des Aspirin. Deutsch Med Wschr 1902, 416:1906. [in German].
21. Gilbert G.B. Unusual idiosyncrasy to aspirin. JAMA 1911, 56:1262.
22. Samter M., Beers R.F. Intolerance to aspirin: clinical studies and consideration of its pathogenesis. Ann Intern Med 1968, 68:875-883.
23. Vanselow N.A., Smith J.R. Bronchial asthma induced by indomethacin. Ann Intern Med 1967, 66:568.
24. Bosso J.V., Creighton D., Stevenson D.D. Flurbiprofen (Ansaid) cross-sensitivity in an aspirin-sensitive asthmatic patient. Chest 1992, 101:856-858.
25. Gniazdowska B., Ruëff F., Przybilla B. Delayed contact hypersensitivity to non-steroidal anti-inflammatory drugs. Contact Dermatitis 1999, 40:63-65.
26. Doña I., Blanca-López N., Cornejo-García J.A., et al. Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: patterns of response. Clin Exp Allergy 2011, 41:86-95.
27. Hedman J., Kaprio J., Poussa T. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 1999, 28:717-722.
28. Kowalski M.L., Demoly P., Pichler W.J., et al. Hypersensitivity to drugs and biological agents. WAO White Book on Allergy 2012, 57-61. WAO. R. Pawankar, W. Canonica, S.T. Holgate (Eds.).
29. Szczeklik A., Gryglewski R.J., Czerniawska-Mysik G. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br Med J 1975, 1:67-69.
30. Szczeklik A. Aspirin-induced asthma: a tribute to John Vane as a source of inspiration. Pharmacol Rep 2010, 62:526-529.
31. Szczeklik A. The cyclooxygenase theory of aspirin-induced asthma. Eur Respir J 1990, 3:588-593.
32. Czerniawska-Mysik G., Szczeklik A. Idiosyncrasy to pyrazolone drugs. Allergy 1981, 36(6):381-384.
33. Pichler W.J. Drug hypersensitivity reactions: classification and relationship to T-cell activation 2007, 168-189. Karger Drug hypersensitivity, Switzerland. W.J. Pichler (Ed.).
34. Stevenson D.D., Sanchez-Borges M., Szczeklik A. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol 2001, 87:177-180.